Cruz Browne

These findings establish a preclinical proof of concept for combating CC by dual targeting of JAK1/2 and DNMT1, and provide support for launching a clinical trial to evaluate the efficacy and safety of this drug combination in patients with CC and other malignant tumors.

An online survey.

To describe how healthcare providers manage…[Read more]

Although it was not an original goal of the task, the collaborative effort between pharmacy instructors, students and the public helped increase awareness of medicines lists through this task.To date, no clinical studies have compared the accuracy of serum procalcitonin (PCT) reference curves. #link# We aimed to validate the diagnostic accuracy of…[Read more]